Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 4/20 | 0.39 |
| ▸ | RCOR1 | Q9UKL0 | 2/20 | 0.36 |
| ▸ | GPR6 | P46095 | 7/20 | 0.35 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.35 |
| ▸ | LCK | P06239 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.34 |
| ▸ | IDH1 | O75874 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6707700 | 0.97 | KDM1A (0.38) | KDM1ARCOR1GPR6MAP2K1LCK | |
| SCHEMBL6708788 | 0.96 | XDH (0.39) | KDM1ARCOR1GPR6LCKFYN | |
| SCHEMBL6708005 | 0.90 | EGLN1 (0.38) | KDM1AGPR6LCKFYN | |
| SCHEMBL6713869 | 0.90 | GRIK1 (0.38) | KDM1ARCOR1PPARG | |
| SCHEMBL6708800 | 0.90 | KDM1A (0.34) | KDM1ALCKFYNBRD4MAOA | |
| SCHEMBL6711788 | 0.90 | KDM1A (0.36) | KDM1ARCOR1XDHCNR2PPARG | |
| SCHEMBL6710160 | 0.89 | TP53 (0.36) | BRD4CNR2PPARG | |
| SCHEMBL6708736 | 0.88 | GPR6 (0.39) | GPR6 | |
| SCHEMBL6710086 | 0.88 | MET (0.38) | KDM1A | |
| SCHEMBL6710259 | 0.88 | BRD4 (0.36) | KDM1ABRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142981-A1 | Antibacterial benzoic acid derivatives | GABRD, PHB1, GABBR1 | KDM1A 620/4885RCOR1 3366/4885GPR6 2607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.